Prinmosyot Type 2 fully automated glycoglobin analysis reagent - Taiwan Registration 931dbae787fd826b335ec0db0aedbeaa
Access comprehensive regulatory information for Prinmosyot Type 2 fully automated glycoglobin analysis reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 931dbae787fd826b335ec0db0aedbeaa and manufactured by TRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECH. The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
The Primmos ULTRA2 fully automated glycoglobin analysis system is a high-pressure liquid chromatography method to quantify glycohemoglobin in normal or diabetic patients in vitro diagnostic tests, which can be used with whole blood or diluted samples.
B Hematology, pathology, and genetics
B.7470 Analysis of glycosylated hemoglobin
import
Dates and Status
Feb 23, 2006
Feb 23, 2021
Sep 19, 2023
Cancellation Information
Logged out
่ช่ก้ตๅ ฅ